Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07526571 · ClinicalTrials.gov registry record · NA
GLOW Study: Effects of Triple Protein in Women
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07526571 is a NA study that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 40 participants.
The verdict
NCT07526571, a NA study, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal test with 2-hour glucose and insulin sampling), complete one acute supervised dose, and then consume a daily supplement for 4 weeks. During the final 14 days, participants will wear a continuous glucose monitor. Outcomes include postprandial glucose AUC, insulin sensitivity, and body composition.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Triple protein support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-04 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07526571
The ClinicalTrials.gov registry entry for NCT07526571 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07526571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07526571 about?
NCT07526571 is a clinical study titled "GLOW Study: Effects of Triple Protein in Women". This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal t...
What is the current status of trial NCT07526571?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-04. Estimated completion is 2026-12-01.
What interventions are being tested in trial NCT07526571?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Triple protein support (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07526571?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.